Camille Edwards, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MBBS, University of the West Indies
BMedSc, University of the West Indies

Dr. Edwards is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine (BUSM). She maintains a clinical practice in hematology at Boston Medical Center (BMC) with a specific research interest in plasma cell disorders such as systemic immunoglobulin light chain (AL) amyloidosis. She is committed to improving the care of vulnerable patient populations using her translational research platform to address unanswered questions encountered in clinical care. After internal medicine residency, she completed hematology and oncology fellowship at BUSM/BMC, obtaining rigorous training through the comprehensive cancer center and the world-renowned BU Amyloidosis Center. Her current research, a collaboration with the Center for Regenerative Medicine (CReM) and BU Amyloidosis Center, focuses on using novel disease models for hematologic malignancies to study the earliest signs of disease, test treatments and develop the most promising therapeutic agents for clinical trials. She is also an active mentor for students and residents, and has a strong passion for teaching and mentoring trainees.

Defining a molecular signature of cardiac tissue dysfunction in systemic immunoglobulin light-chain amyloidosis
07/01/2020 - 06/30/2022 (PI)
American Society of Hematology

SPORE in Multiple Myeloma
06/01/2021 - 05/31/2022 (Subcontract PI)
Dana-Farber Cancer Institute NIH NCI

M13-494: A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple Myeloma
10/21/2020 - 10/20/2023 (PI)
AbbVie Inc.


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles. PMID: 35731907
  2. Hughes DM, Henshaw L, Blevins F, Edwards C, Lerner A, Sloan JM, Sanchorawala V. Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22(8):566-568.View Related Profiles. PMID: 35367193
  3. Edwards CV, Rao N, Bhutani D, Mapara M, Radhakrishnan J, Shames S, Maurer MS, Leng S, Solomon A, Lentzsch S, Eisenberger A. Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis. Blood. 2021 12 23; 138(25):2632-2641. PMID: 34521113; PMCID: PMC8703360; DOI: 10.1182/blood.2020009039;
  4. Szalat RE, Gustine J, Sloan JM, Edwards CV, Sanchorawala V. Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. Am J Hematol. 2022 01 01; 97(1):79-89.View Related Profiles. PMID: 34739735
  5. Edwards CV, Bhutani D, Mapara M, Radhakrishnan J, Shames S, Maurer MS, Leng S, Wall JS, Solomon A, Eisenberger A, Lentzsch S. One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. Amyloid. 2019; 26(sup1):115-116. PMID: 31343323
  6. Nwabudike SM, Edwards CV, Akinboro O, Quinn K, Sarosiek S, Ko N. Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer. Case Rep Hematol. 2018; 2018:9249506.View Related Profiles. PMID: 30647983; PMCID: PMC6311830; DOI: 10.1155/2018/9249506;
  7. Edwards C, Sideeg A, Kunadu A, Sammut A, Redwood E. Adult- onset Still’s Disease. American College of Physicians Hospitalist Journal. 2016; 35-36.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 2021 and 2022


2020-2021 Boston University: American Society of Hematology Research Training Award
2019 Boston University School of Medicine: Residents’ Teaching Award
2018 Boston University School of Medicine: Fellow Immersion Training in Addiction Medicine Scholarship Award
2017 Amyloidosis Foundation: Junior Researcher Travel Award for the XVIth Annual Symposium

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
  • Phone (see 'Contact Info')

820 Harrison Ave
Boston MA 02118
Google Map

Edwards's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department